Range
31.65 - 33.68
Vol / Avg.
199.2K/710.3K
Div / Yield
-
52 Wk
16.69 - 42.36
Mkt Cap
2.4B
Payout Ratio
-
Open
31.86
P/E
-
EPS
-1.08
Shares
71M
Outstanding
71M
Total Float
49.9M
load more
Sector: Health Care.Industry: Biotechnology
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB680, and Zimberelimab. Arcus conducts clinical trials for different types of cancers such as Prostate, Lung, Colorectal, Pancreatic, and others. The company operates through the single segment being the business of developing and commercializing immunotherapies.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-09
REV
Q1 2021Est.ActualSurprise
EPS-0.840-1.080 -0.2400
REV13.340M9.461M-3.879M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
RCUSArcus Biosciences5.81%2.4B

Arcus Biosciences Frequently Asked Questions

Q

How do I buy Arcus Biosciences (RCUS) stock?

A

You can purchase shares of Arcus Biosciences (NYSE: RCUS) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Arcus Biosciences's (RCUS) competitors?

Q

What is the target price for Arcus Biosciences (RCUS) stock?

A

The latest price target for Arcus Biosciences (NYSE: RCUS) was reported by SVB Leerink on June 24, 2021. The analyst firm set a price target for 63.00 expecting RCUS to rise to within 12 months (a possible 88.00% upside). 7 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Arcus Biosciences (RCUS)?

A

The stock price for Arcus Biosciences (NYSE: RCUS) is $33.51 last updated Today at 6:58:30 PM.

Q

Does Arcus Biosciences (RCUS) pay a dividend?

A

There are no upcoming dividends for Arcus Biosciences.

Q

When is Arcus Biosciences (NYSE:RCUS) reporting earnings?

A
Arcus Biosciences’s Q2 earnings are confirmed for after-market on August 9, 2021.
Q

Is Arcus Biosciences (RCUS) going to split?

A

There is no upcoming split for Arcus Biosciences.

Q

What sector and industry does Arcus Biosciences (RCUS) operate in?

A

Arcus Biosciences is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NYSE.